Roth Capital raised the firm’s price target on Cinemark (CNK) to $37 from $36 and keeps a Buy rating on the shares. Following a better than expected Q1 box office, Cinemark remains in good position to benefit from an improved movie slate in 2026 and in 2027, and as the box office improves, the company should see margin expansion, higher free cash flow, and increased capital returns, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark price target raised to $34 from $30 at B. Riley
- Ellison commits to 45-day movie release window, Variety reports
- Cinemark price target raised to $36 from $32 at Wells Fargo
- Cinemark price target raised to $35 from $31 at JPMorgan
- Cinemark achieves all-time high five-day Easter weekend box office